| Study Of Single Ascending And Multiple Doses Of PF-04447943 In Japanese Subjects. (NCT00959803) | Pfizer | 2009-08-01 |
| A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers (NCT00959426) | Pfizer | 2009-08-01 |
| To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-04531083 In Healthy Male Subjects (NCT00992316) | Pfizer | 2009-08-01 |
| Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer (NCT00880009) | Pfizer | 2009-07-30 |
| Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma (NCT00868608) | Pfizer | 2009-07-30 |
| Study Evaluating Pharmacovigilance Of Refacto AF (NCT00895037) | Pfizer | 2009-07-17 |
| Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance] (NCT01145352) | Pfizer | 2009-07-01 |
| A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1 (NCT00824369) | Pfizer | 2009-07-01 |
| A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease (NCT00960531) | Pfizer | 2009-07-01 |
| A Study Estimating The Time Course Of PF-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers (NCT00928278) | Pfizer | 2009-07-01 |
| A Pharmacokinetic And QT Study Of CP-751,871 In Healthy Subjects (NCT00926263) | Pfizer | 2009-07-01 |
| Relative Drug Exposures Of Two Formulations of PF-02341066 (NCT00939731) | Pfizer | 2009-07-01 |
| A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers (NCT00931073) | Pfizer | 2009-07-01 |
| The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects (NCT00914667) | Pfizer | 2009-07-01 |
| This Is An Open-Label Study To Evaluate Fesoterodine Plus "Your Way" Patient Support Plan In Patients With Symptoms Of Overactive Bladder (NCT00943735) | Pfizer | 2009-07-01 |
| Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease (NCT00744978) | Pfizer | 2009-07-01 |
| Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis (NCT00936065) | Pfizer | 2009-07-01 |
| A Bioequivalence Study Of AG-013736 Tablets In Healthy Volunteers (NCT00905814) | Pfizer | 2009-07-01 |
| Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients (NCT00910273) | Pfizer | 2009-07-01 |
| A Trial In Patients With Advanced Cancer And Leukemia (NCT00878189) | Pfizer | 2009-06-25 |
| Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis (NCT00883896) | Pfizer | 2009-06-18 |
| A Study of Tanezumab in Adults With Chronic Low Back Pain (NCT00876187) | Pfizer | 2009-06-15 |
| Tanezumab in Osteoarthritis of the Hip or Knee (2) (NCT00863304) | Pfizer | 2009-06-09 |
| Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma (NCT00867087) | Pfizer | 2009-06-08 |
| Bioavailability Study Comparing Modified Release To Immediate Release Apixaban Tablets In Healthy Volunteers (NCT00914641) | Pfizer | 2009-06-01 |
| A Non Interventional Study To Asses The Safety, Effectiveness And Tolerability Of Quinapril (Acupil®) In An Indian Population (NCT00930722) | Pfizer | 2009-06-01 |
| Food Effect Study Of AG-013736 In Healthy Volunteers (NCT00918632) | Pfizer | 2009-06-01 |
| A Bioequivalence Study Of 8 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects (NCT00902681) | Pfizer | 2009-06-01 |
| Safety And Efficacy Of Rifabutin In HIV Patients (NCT00810446) | Pfizer | 2009-06-01 |
| Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options (NCT00945555) | Pfizer | 2009-06-01 |
| Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder (NCT00887224) | Pfizer | 2009-06-01 |
| Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab (NCT00916617) | Pfizer | 2009-06-01 |
| Bioequivalence Study Comparing Artesunate Tablet To Arsuamoon® Tablets (Guilin-China) In Healthy Subjects (NCT00894374) | Pfizer | 2009-06-01 |
| A Phase 1 Trial To Assess The Safety And Pharmacokinetics Of Single, Ascending, Oral Doses Of Dimebon In Healthy Adults (NCT00907322) | Pfizer | 2009-06-01 |
| A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects (NCT00894660) | Pfizer | 2009-06-01 |
| A Study To Assess The Effect Of PF-03526299 On Lung Function Following An Allergen Challenge In Asthmatic Subjects (NCT00877539) | Pfizer | 2009-06-01 |
| Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer (NCT00942968) | Pfizer | 2009-06-01 |
| A Study Comparing Blood Levels After Single-Dose Administration Of Artesunate Sachets (Pfizer) Versus Single-Dose Administration Of Arsuamoon® Tablets (Guilin-China) In Healthy Subjects (NCT00875030) | Pfizer | 2009-06-01 |
| Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients (NCT00895583) | Pfizer | 2009-06-01 |
| Systematic Review And Meta-Analysis Of Psoriasis Treatments. (NCT01425138) | Pfizer | 2009-06-01 |
| CP-690,550 and Midazolam Drug-Drug Interaction Study (NCT00902460) | Pfizer | 2009-06-01 |
| Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy (NCT00848354) | Pfizer | 2009-06-01 |
| A Phase I Open-Label Study of the Effects of Tacrolimus and Cyclosporine on CP-690,555 in Healthy Volunteers (NCT00860496) | Pfizer | 2009-06-01 |
| A Study to Estimate the Time Course of PF-00241939 Concentration in the Blood Following Dosing by Oral Inhalation From Dry Powder Inhalers (NCT00867282) | Pfizer | 2009-06-01 |
| Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis (NCT00838565) | Pfizer | 2009-05-20 |
| Tanezumab and Nerve Function In Arthritis Patients (NCT00863772) | Pfizer | 2009-05-18 |
| Study Evaluating Ibuprofen 600 mg Extended Release (ER) For Dental Pain (NCT00913627) | Pfizer | 2009-05-07 |
| Tanezumab In Osteoarthritis Of The Knee (2) (NCT00830063) | Pfizer | 2009-05-05 |
| A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications (NCT00856544) | Pfizer | 2009-05-01 |
| Study In Patients With Kidney Cancer Treated With Sutent (NCT00873210) | Pfizer | 2009-05-01 |
| Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice (NCT00922766) | Pfizer | 2009-05-01 |
| A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children (NCT00836875) | Pfizer | 2009-05-01 |
| Non-Interventional Study With Aricept® Evess (NCT00889603) | Pfizer | 2009-05-01 |
| Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan (NCT00871494) | Pfizer | 2009-05-01 |
| Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease (NCT00895895) | Pfizer | 2009-05-01 |
| Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (NCT00796666) | Pfizer | 2009-05-01 |
| A Bioequivalence Study Of 4 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects (NCT00902187) | Pfizer | 2009-05-01 |
| A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers. (NCT00862667) | Pfizer | 2009-05-01 |
| The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects (NCT00911235) | Pfizer | 2009-05-01 |
| Maintenance of Efficacy. (NCT00796601) | Pfizer | 2009-05-01 |
| Evaluation Of The Relative Bioavailability Of PF-04457845 Tablet To Solution Formulation And Food Effect In Healthy Subjects (NCT00918164) | Pfizer | 2009-05-01 |
| Study Evaluating Renal Cell Carcinoma Risk Factors (NCT00927043) | Pfizer | 2009-05-01 |
| An Open Label, Randomized, Crossover Study To Estimate The Pharmacokinetics And Evaluate The Safety Following A Single Dose Of Azithromycin 2g Extended-Release Powder For Oral Suspension With A 3-Day Dosing Regimen Of Azithromycin 500mg Tablet In Chinese Healthy Male Subjects (NCT00879983) | Pfizer | 2009-05-01 |
| A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis (NCT00853385) | Pfizer | 2009-05-01 |
| Study Evaluating Safety Of Patients Switching To ReFacto AF In Usual Care Settings (NCT00884390) | Pfizer | 2009-05-01 |
| A Phase 1 Study To Estimate The Effects Of PD 0332334 On Lithium Pharmacokinetics In Healthy Subjects (NCT00820794) | Pfizer | 2009-05-01 |
| A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects (NCT00859807) | Pfizer | 2009-05-01 |
| A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone (NCT00545129) | Pfizer | 2009-04-29 |
| Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401) (NCT00894686) | Pfizer | 2009-04-26 |
| A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects (NCT00830427) | Pfizer | 2009-04-15 |
| A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension (NCT00853112) | Pfizer | 2009-04-01 |
| Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Surgery For Long Bone Fracture (NCT00824564) | Pfizer | 2009-04-01 |
| A Study Of Indian Patients Receiving Therapy For Systemic Fungal Infections (NCT00721578) | Pfizer | 2009-04-01 |
| Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration (NCT00877032) | Pfizer | 2009-04-01 |
| A Study To Evaluate Whether Food Affects The Plasma Drug Levels Of A 35 mg Single Dose Of PF-04447943 Taken Orally In Healthy Adult Participants (NCT00886093) | Pfizer | 2009-04-01 |
| Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule (NCT01058824) | Pfizer | 2009-04-01 |
| A Four-Way Cross-Over Study To Compare The Plasma Concentrations Of PF-02413873 After Oral Administration Of Several Doses As Suspension And As Tablets. (NCT00857571) | Pfizer | 2009-04-01 |
| Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer (NCT00678626) | Pfizer | 2009-04-01 |
| Bioavailability Study Of PF-00868554 Administered As 3x250mg Oral Tablets (Wet Granulate, 3x250mg Oral Tablets (Dry Granulate) And 750mg Solution Under Fed State (NCT00861458) | Pfizer | 2009-04-01 |
| Study Evaluating Safety And Tolerability Of Meningococcal B Rlp2086 Vaccine In Healthy Adults (NCT00879814) | Pfizer | 2009-04-01 |
| An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida (NCT00805740) | Pfizer | 2009-04-01 |
| Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer (NCT00842244) | Pfizer | 2009-04-01 |
| A Study to Evaluate the Safety of Apixaban in Acute Coronary Syndrome (ACS) Japanese Patients (NCT00852397) | Pfizer | 2009-04-01 |
| Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit (NCT00832650) | Pfizer | 2009-04-01 |
| A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults (NCT00855101) | Pfizer | 2009-04-01 |
| A First In Human Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Single Rising Doses In Healthy Adult Volunteers (NCT00938301) | Pfizer | 2009-04-01 |
| A Study To Investigate Safety, Tolerability, And Pharmacokinetics Of PF-00868554 In Japanese Healthy Adult Volunteers (NCT00875628) | Pfizer | 2009-04-01 |
| A Study To Assess The Effect Of PF-03893787 On Lung Function Following An Allergen Challenge In Asthmatic Subjects (NCT00856687) | Pfizer | 2009-04-01 |
| Quillivant Oral Suspension (Quillivant XR) in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) (NCT00904670) | Pfizer | 2009-04-01 |
| Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections (NCT00752219) | Pfizer | 2009-03-31 |
| An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis (NCT00826514) | Pfizer | 2009-03-25 |
| A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1 (NCT00823979) | Pfizer | 2009-03-25 |
| Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung (NCT00818441) | Pfizer | 2009-03-11 |
| Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years (NCT00857896) | Pfizer | 2009-03-01 |
| Study Evaluating Predictors of Response in Patients With Ankylosing Spondylitis (NCT00900796) | Pfizer | 2009-03-01 |
| Impact Of Smoking Cessation Treatment Reimbursement On The Quit Rates In Smokers Motivated To Quit (NCT00818207) | Pfizer | 2009-03-01 |
| Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Children (NCT00824655) | Pfizer | 2009-03-01 |
| Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent (NCT00836745) | Pfizer | 2009-03-01 |
| Study Evaluating Long-Term Safety of Desvenlafaxine Succinate Sustained Release With Japanese Adult Subjects in Major Depressive Disorder (MDD) (NCT00831415) | Pfizer | 2009-03-01 |
| Comparison Of 5 CP-690,550 Doses Vs. Placebo, For The Treatment Of Rheumatoid Arthritis In Japan (NCT00687193) | Pfizer | 2009-03-01 |